Sec Form 4 Filing - Melrose Evan S @ Spindletop Health Acquisition Corp. - 2021-11-08

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Melrose Evan S 2. Issuer Name and Ticker or Trading Symbol Spindletop Health Acquisition Corp. [ SCHAU] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) CEO and CFO (Last) (First) (Middle) C/O SPINDLETOP HEALTH ACQUISITION CORP., 3571 FAR WEST BLVD., SUITE 108 3. Date of Earliest Transaction (MM/DD/YY) 11/08/2021 (Street) AUSTIN, TX78731 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Private Warrants $ 11.5 11/08/2021 P 12,600,000 ( 1 ) ( 2 ) Class A Common Stock 12,600,000 $ 1 12,600,000 I By Spindletop Health Sponsor Group, LLC( 3 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Melrose Evan S C/O SPINDLETOP HEALTH ACQUISITION CORP. 3571 FAR WEST BLVD., SUITE 108 AUSTIN, TX78731 X CEO and CFO Signatures /s/ Evan Melrose 11/11/2021 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Private Warrants will become exercisable on the later of 30 days after the completion of the Company's initial business combination or 12 months from the completion of the Company's initial public offering. ( 2 )The Private Warrants will expire on the fifth anniversary of the Company's completion of its initial business combination. ( 3 )The Private Warrants are held directly by Spindletop Health Sponsor Group, LLC (the "Sponsor"). The Private Warrants held by the Sponsor are beneficially owned by Dr. Evan Melrose, Spindletop Health Acquisition Corp.'s Chief Executive Officer and Chief Financial Officer. Dr. Melrose is also the Manager of the Sponsor, who has sole voting and dispositive power over all securities held by the Sponsor.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.